STOCK TITAN

John E. Kao (ALHC) reports multiple 10b5-1 stock sales through March 2026

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

ALHC reported Form 144 sales by or for John E. Kao under 10b5-1 plans. The excerpt lists multiple reported dispositions of Common stock, including sales of $1,133,514.66 across transactions on 12/29/2025 and repeated sales of $3,273,558.00 and similar amounts in early 2026. The filings show routine plan-based sales rather than corporate actions.

Positive

  • None.

Negative

  • None.

Insights

Reported sales are executed under pre-arranged 10b5-1 plans and represent routine dispositions.

The excerpt lists multiple Common stock sales attributed to John E. Kao and the JEK Trust U/A DTD 02/08/2021, including transactions on 01/12/2026 and 03/10/2026. Several entries explicitly cite a 10b5-1 Sales Plan, indicating pre‑arranged trading.

Cash flow recipients and aggregate remaining holdings are not disclosed in the excerpt; subsequent SEC filings would show settlement/stock‑count effects. The transactions are factual disclosures of dispositions, not company operational developments.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did ALHC insiders report in the Form 144?

The filing reports multiple sales of Common stock by John E. Kao and entities associated with him. Entries include transactions on 12/29/2025, 01/12/2026, and through March 2026, some made under a 10b5-1 sales plan.

Were the sales by John E. Kao part of a 10b5-1 plan?

Yes. Several sales in the excerpt — including trades on 03/10/2026 and 02/10/2026 — are labeled as executed under a 10b5-1 Sales Plan for JEK TRUST U/A DTD 02/08/2021, indicating pre‑arranged dispositions.

How large were the reported transactions in the Form 144?

The excerpt lists individual cash amounts for each sale, for example $1,133,514.66 on 12/29/2025 and sales of $3,273,558.00 on 03/10/2026. Each row shows shares and corresponding gross proceeds.

Does Form 144 disclose who receives the sale proceeds?

No. The excerpt records seller names and gross proceeds per transaction but does not state the payee or use of proceeds. It lists the filer, the security, share counts, and dollar amounts without specifying distribution of cash.

Do these Form 144 entries change ALHC corporate governance or operations?

No. The reported entries are personal or trust dispositions by an individual insider and do not describe corporate governance changes, operational events, or material company actions in the provided excerpt.
Alignment Healthcare, Inc.

NASDAQ:ALHC

View ALHC Stock Overview

ALHC Rankings

ALHC Latest News

ALHC Latest SEC Filings

ALHC Stock Data

3.58B
184.05M
Healthcare Plans
Hospital & Medical Service Plans
Link
United States
ORANGE